Investigating how a specific transporter affects myelin regeneration in the brain
Immunoregulation in CNS remyelination
This study is looking at how blocking a certain protein can help repair the protective covering around nerves in people with multiple sclerosis, by seeing how it affects immune cells that help with healing.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgetown University NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project ID | NIH-11168248 on NIH RePORTER |
What this research studies
This research focuses on understanding how inhibiting a specific amino acid transporter, Slc7a5, can enhance the regeneration of myelin in the central nervous system, particularly in conditions like multiple sclerosis. The study will explore how this inhibition affects the activity of immune cells called microglia and macrophages, which play a crucial role in the healing process of demyelinated lesions. By examining the interactions between these immune cells and oligodendrocytes, the cells responsible for myelin production, the research aims to uncover new therapeutic strategies that could improve remyelination and reduce disability in patients with multiple sclerosis.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with multiple sclerosis who are experiencing demyelination.
Not a fit: Patients with other neurological disorders that do not involve demyelination may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that enhance myelin regeneration, potentially improving outcomes for patients with multiple sclerosis.
How similar studies have performed: Previous research has shown promising results in enhancing remyelination through similar approaches, indicating potential for success in this study.
Where this research is happening
Washington, United States
- Georgetown University — Washington, United States (Active)
Researchers
- Principal investigator: Huang, Jeffrey K — Georgetown University
- Study coordinator: Huang, Jeffrey K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.